With decades of clinical engineering and capital lifecycle experience, Carol Davis-Smith will guide health systems on equipment planning under budget pressure.
enBio Corp, a provider of healthcare technology management (HTM), biomedical engineering, hospital bed management, healthcare staffing, and CMS compliance services, announced that Carol Davis-Smith, MS, CCE, FACCE, AAMIF, has partnered with the organization as senior advisor of strategic capital planning.
With more than 30 years of clinical engineering, HTM operations, capital equipment strategy, and executive healthcare experience, Davis-Smith will lead enBio’s enterprise-wide strategic capital planning initiative to help hospitals and health systems build data-driven equipment strategies designed to strengthen patient safety, support clinicians, and improve financial performance.
“Carol is truly one of the most respected voices in the HTM industry,” says Arthur Zenian, founder and CEO of enBio Corp, in a release. “Her track record of designing capital strategies for major health systems is extraordinary. Her insight and leadership immediately elevate the sophistication of what we can offer our customers.”
Greg Aghamanoukian, president of enBio Corp, adds in a release, “Health systems are under tremendous pressure to make smarter capital decisions—especially with aging fleets and constrained budgets. Carol gives our clients something incredibly valuable: clarity. She helps them understand what to replace, when to replace it, and how to do it in a way that aligns clinical needs with long-term financial stability.”
Davis-Smith’s Background
Davis-Smith previously served as vice president of clinical technology at Kaiser Permanente, overseeing nearly 400,000 assets across seven regions. She also spent 16 years with Premier Inc, supporting capital lifecycle planning and technology assessment for health systems nationwide.
She is the president of Carol Davis-Smith & Associates, LLC, director of the clinical engineering internship program at the University of Connecticut, and has held key leadership roles with AAMI and ACCE. She is a certified clinical engineer, an ACCE and AAMI Fellow, and holds engineering degrees from the University of Arizona and the University of Dayton.
Leading enBio’s Strategic Capital Planning Initiative
In her new role, Davis-Smith will guide hospitals and health systems in building data-driven capital equipment plans. Her work will include multi-year replacement forecasting, evaluation of emerging technologies, differentiation of routine versus construction-related capital, and support for RFI/RFP and acquisition processes. She will also partner with HTM leaders to assess operational readiness and ensure that capital decisions align with clinical needs, safety standards, and financial priorities.
“Capital planning is ultimately about protecting patients and enabling caregivers to deliver safe, reliable care,” says Davis-Smith in a release. “I’m excited to partner with enBio and its clients to build strategic equipment roadmaps that are objective, defensible, and actionable.”
ID 410187692 © Natalya Kosarevich | Dreamstime.com
We Recommend for You:
